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In Brief
 
Integration of Damage Signals before 
Commitment to Death
 
Programmed cell death (apoptosis) is controlled in part by
the Bcl-2 family of apoptosis-promoting (Bak, Bax, Bid)
 
and apoptosis-inhibiting (Bcl-2, Bcl-x
 
L
 
) proteins. Begin-
ning on page 903, Griffiths et al. examine what may be one
of the earliest events in apoptosis: the effects of damage
signals on the pro-apoptotic protein Bak. Using flow cy-
tometry, they show that although the amount of Bak does
not change early on, an epitope at Bak’s NH
 
2
 
 terminus be-
comes accessible after various apoptosis-inducing events,
DNA strand breaks and changes in protein phosphory-
lation and transcription, are induced by etoposide, stau-
 
rosporine, or dexamethasone. However, the epitope is
not exposed by activation of the Fas-dependent apoptotic
pathway.
 
In untreated cells, Bcl-x
 
L
 
 and Bak coimmunoprecipitate
and immunofluorescence data reveal a close association be-
tween the two proteins and mitochondria. Dissociation of
Bcl-x
 
L
 
 from Bak, perhaps due to exposure of Bak’s NH
 
2 
 
ter-
minus, could account for the decreased coimmunoprecipita-
tion observed after cell damage and commitment to death.
Another pro-apoptotic protein in the Bcl-2 family, Bax,
also undergoes a change in conformation, exposing its
NH
 
2
 
-terminal domain, in cells undergoing apoptosis. Using
HeLa cells, Desagher et al. (page 891) help answer the
question: do the apoptosis inhibitors Bcl-x and Bcl-2 in-
hibit the pro-apoptotic Bax, or are the anti-apoptotic influ-
ences of Bcl-x and Bcl-2 antagonized by Bax? The data
from Jean-Claude Martinou’s lab suggest that Bax may be
the active killer.
Others have previously described a change in Bax con-
formation leading to exposure of the NH
 
2
 
-terminal domain
in a solution containing nonionic detergents. The latest re-
sults indicate that Bax’s structural change is linked to the
translocation of a third pro-apoptotic protein, Bid, from
the cytosol to mitochondria. The conformational change is
also linked to the release of cytochrome c from mitochon-
dria. In isolated mitochondria, the Bax structural change
and cytochrome c release require direct binding of Bid.
Both Bcl-2 and Bcl-x, but not caspase inhibitors, prevent
the change in Bax conformation. Bid alone elicits little re-
lease of cytochrome c in mitochondria from Bax-deficient
tumor cells, whereas Bax and Bid together significantly in-
crease release. Thus, Bax appears to have an essential role
in the release of cytochrome c from mitochondria induced
by Bid.
Cytochrome c release need not be irreversible. Marti-
nou et al. (page 883) indicate that cytochrome c can be re-
leased from mitochondria without any obvious damage to
the outer mitochondrial membrane in primary cultured
sympathetic neurons. This observation is supported by the
finding that mitochondria from neurons depleted of cyto-
chrome c can recover their cytochrome c content when
NGF is added.
When NGF is eliminated, the neuronal mitochondria
lose cytochrome c content. Normally this leads to cell
death but this fate can be avoided by treating the cells with
caspase inhibitors. The recovery of cytochrome c content
after reintroduction of a trophic factor, together with the
apparent integrity of the organelles indicated by morpho-
metric electron microscopy, suggests to Martinou that the
“outer mitochondrial membrane has not been damaged
during the NGF deprivation.” This insight contradicts the
popular hypothesis that cytochrome c release reflects irre-
versible damage to mitochondria. It implies the existence
of a control process that may involve a specific channel.
One likely candidate is Bax.
 
Mutational Analysis
 
Troponin I and Myosin Heavy Chain
 
Kronert et al. (page 989) use genetic analysis to identify in-
teractions between troponin I and other muscle proteins dur-
 
ing muscle contraction. They screened 
 
Drosophila melano-
gaster
 
 for mutations that suppress the held-up wing position
of the troponin I 
 
hdp2
 
 mutation, which produces a degenera-
tive muscle syndrome. This approach revealed four genetic
suppressors, all of which are located on chromosome 2.
Genetic complementation tests with known myosin heavy
chain alleles indicated that the four mutations are alleles
of myosin heavy chain (Mhc), and cloning and sequencing
of the 
 
Mhc
 
 gene from each of the mutants revealed that
these mutations are all located in the head of this thick-fila-
ment molecule. Genetic studies also indicated that specific
changes in Mhc structure, as opposed to changes in myosin
function or levels, account for suppression of the held-up
wing phenotype. The degree of genetically determined
muscle dysfunction in this model can be increased or de-
creased by mutations in other proteins involved in muscle
contraction. Such a system could provide an opportunity
to identify how the interactions of genes might influence
the severity of disease in other organisms.
 
Cell Division in Worms
 
Gönczy et al. (page 927) use a classical microscopy tech-
nique, video-enhanced, time-lapse Nomarski DIC micros-
copy, to examine cell division processes in their large scale
mutational analysis of the one-cell stage of 
 
Caenorhabditis
elegans
 
.
“We have a direct way of looking at cell division pro-
 
cesses in great detail as they are happening, without fixing the
cell,” says first author Pierre Gönczy. The method provides
a straightforward way to screen worm mutants—in this
instance, 160 maternal-effect, embryonic-lethal mutations
on chromosome III—and determine their phenotypes.
Among the 48 mutations at 34 loci, some cause no appar-
ent defect in the microtubule-dependent processes that
precede spindle assembly, but mutants fail to form a bipo-
lar spindle. Others are specifically defective in cytokinesis.
The loci have already been mapped by deficiencies at dis- 
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crete regions of chromosome III; the next step will be to
identify individual genes at these loci.
 
Modulating Morphogenic Proteins
 
Bone is deposited on cartilage during endochondral ossifi-
cation, so cartilage formation determines the pattern of
the developing skeleton. Type II collagen is the major ex-
tracellular matrix protein in cartilage, and it may also func-
tion in induction of chondrogenesis. It is formed from one
of two precursors: type IIA and type IIB. Type IIA procol-
lagen contains an additional 69 amino acid, cysteine-rich
domain at its amino terminus relative to type IIB.
Zhu et al. (page 1069) now provide evidence that the
additional amino acid domain in type IIA procollagen has
a significant role in chondrogenesis. Using antibodies di-
rected against three domains of type IIA procollagen, they
detect the NH
 
2
 
-terminal propeptide, the fibrillar domain,
and the COOH-terminal propeptides of the molecule as
cartilage is deposited during bone development. Immuno-
 
electron microscopy with antibodies to the NH
 
2
 
-terminal
propeptide indicated that type IIA procollagen fibrils are
present in the extracellular matrix. Recombinant NH
 
2
 
-ter-
minal propeptide binds to TGF-
 
b
 
1 and BMP-2, which are
both capable of inducing bone formation, but not to bFGF
or IGF-1, which are also involved in chondrogenesis.
The findings support the suggestion that the type IIA
NH
 
2
 
-terminal propeptide modulates the function of mor-
phogenetic proteins during chondrogenesis. A similar
protein domain in the 
 
Xenopus
 
 protein Chordin, and the
 
Drosophila
 
 protein Sog, binds to morphogenic factors
(BMP-4 and Decapentaplegic, respectively) to establish
the embryonic dorsal-ventral axis. These findings suggest a
novel function for the collagen II NH
 
2
 
-terminal propep-
tide and may establish a mechanistic paradigm for the reg-
ulation of pattern formation in the basic body plan and in
the skeleton.
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